AI assistant
Sending…
INSMED Inc — Director's Dealing 2021
Mar 12, 2021
30150_dirs_2021-03-12_f422bc78-5517-4c0f-922a-e8447efc6e76.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2021-03-08
Reporting Person: Schaeffer Orlov S Nicole (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-08 | Common Stock | M | 4709 | $20.49 | Acquired | 45629 | Direct |
| 2021-03-08 | Common Stock | F | 2479 | $38.92 | Disposed | 43150 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-08 | Stock Option (right to buy) | $20.49 | M | 4709 | Acquired | 2024-01-04 | Common Stock (4709) | Direct |
Footnotes
F1: Stock options granted under the Company's 2013 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
More from INSMED Inc
Regulatory Filings
2026
May 15
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19